Inex

html xmlns=”http://www.w3.org/1999/xhtml”>

abacavir


access (to services)


addiction


see also substance abuse

adherence (to treatment)


adjustment disorder


adjuvant therapies


Africa


African Americans


ageing


HIV-related neurocognitive disorders and

agraphia


AIDS mania, see also mania


AIDSTAR-One


ALCAM


alcohol use


impact on health outcomes

see also substance abuse

alexia


Alzheimer’s disease


American Academy of Neurology (AAN)


amitriptyline


amphetamines


see also methamphetamine

amprenavir


amyloid plaque formation


anhedonia


animal studies


antidepressants


interactions with antiviral therapies

non-response

norepinephrine-dopamine reuptake inhibitors (NDRI)

selective serotonin reuptake inhibitors (SSRI)

serotonin norepinephrine reuptake inhibitors (SNRI)

tricyclic

antipsychotics


antiretroviral treatments (ART)


adherance to

adherence to

adjuvant treatments

chronic disorders and

HIV-associated neurocognitive disorder (HAND) and

injection drug use and

interactions with other drugs

low and middle-income countries

neurocognitive symptoms as treatment outcomes

neurotoxicity

non-nucleoside reverse transcriptase inhibitors (NNRTI)

antiretroviral treatments (ART), cont.


nucleoside/nucleotide reverse transcriptase inhibitors (NRTI)

protease inhibitors (PI)

stress and

anxiety disorders


behavioural therapies

epidemiology

medication

risk factors

apathy


aphasia


APOBEC


apolipoprotein E


astrocytes


asymptomatic neurocognitive impairment (ANI)


diagnostic criteria

atazanavir


Australia


azidothymidine


 


behavioural therapies


for ART adherence

biobehavioural methods


bipolar disorder


blood transfusion


blood-brain barrier (BBB)


brain imaging


brain microvascular endothelial cell (BMVEC) membrane


Brazil


buprenorphine


bupropion


Butabika National Referral Mental Hospital


 


California computerized assessment package (CAL-CAP)


Cambodia


cannabis see marijuana


Cape Town


carbamazepine (CBZ)


Caribbean


cART see antiretroviral treatments


CCR5 receptor


CD4 cell count


HAND and

CD99


Centers for Disease Control (CDC)


central nervous system (CNS)


CEP-1347


cerebrospinal fluid (CSF) studies


chemokines


children


distress mechanisms

HIV-positive

parental illness

parental relationships

psychological distress

China


chlorpromazine


clozapine


CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER)


CNS penetration/effectiveness (CPE) rank


cocaine


Cochrane Library


cognitive impairment


Cognitive Intervention Trial-2 (CIT-2)


cognitive rehabilitation


cognitive tests


cognitive-behavioural therapy (CBT)


coma


combination antiretroviral therapy (cART) see antiretroviral treatments


Concerted Action on Seroconversion to AIDS and Death in Europe (CASCADE)


condom use


contingency management (CM)


Coping with HIV/AIDS in the Southeast (CHASE)


cost-saving


counselling


Cournos, Francine


CPI-1189


cytokines


 


darunavir


dehydroepiandrosterone


delavirdine


delirium


dementia, HIV-associated see HIV-associated dementia


demoralization


depression


aetiology

behavioural therapies

co-morbitities

diagnosis

epidemiology

HIV pathology and

impact on health outcomes

major depressive disorder

outcomes

risk factors

screening

treatment

desipramine


desvenlafaxine


DHPG


diazepam


didanosine


diffusion tensor imaging, (DTI)


disinhibition


distress


donor funding


drug interactions


DSM-IV


duloxetine


 


educational attainment


efavirenz

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jun 8, 2016 | Posted by in PSYCHIATRY | Comments Off on Inex

Full access? Get Clinical Tree

Get Clinical Tree app for offline access